Rocket Lab Is Up 28% in a Year, Down 57% From May’s High: Take Profits, or Load Up?
Rocket Lab (RKLB) stock is up 28% over the past year but down 57% from its May high. The company reported record Q3 revenue of $268 million, up 73%, and a backlog of $3.57 billion. The acquisition of Iridium Communications was funded with 29.3 million new shares, and the Neutron rocket's first launch has been delayed to 2027. Analysts expect revenue growth but caution about the stock's high valuation until a Neutron launch date is set.
How this was made
The 30-second read
Why it matters
Earnings beat but loss widened; guidance above expectations may support price, but launch delay adds risk.
Market read
Primary earnings disclosure for a niche aerospace firm; actionable for short‑term traders.
What to watch
Potential cost synergies from Iridium acquisition and higher Neutron contract pricing.
Background
Rocket Lab reported Q3 results and forward guidance, while noting a delayed Neutron launch and ongoing Iridium acquisition.
Ticker impact
Q3 results disclosed revenue $268M (+73%) and backlog $3.57B, plus guidance $270‑$290M, marking the first public release of these numbers.
likely modest pressure as investors weigh launch delay against revenue beat
New earnings and guidance are primary disclosure; delay of key rocket adds uncertainty, outweighing short‑term beat.
Market effects
Highlights challenges in small‑satellite launch market, may pressure peers like Astra and Virgin Orbit.
U.S. space sector sees mixed sentiment; investors may rotate to larger aerospace firms.
Limited to niche space launch industry, no broad market effect.
Counterpoint
Delay could be temporary; backlog and Iridium deal may drive upside if Neutron launches in 2027.
Key entities
- companyRocket Lab
U.S. listed small‑satellite launch provider
- companyIridium Communications
Satellite communications firm being acquired by Rocket Lab
